Navigation Links
Study Measures Real-World Comparative Effectiveness of Asthma Controller Medications
Date:7/8/2008

l-world safety and effectiveness of therapeutics; offering insight to best utilize this evidence; and communicating these findings to health care decision-makers. The company's work is increasingly used to support evidence-based medicine, process improvement and patient-reported outcomes.

About WellPoint, Inc.

WellPoint, Inc. is the largest publicly traded commercial health benefits company in terms of membership in the United States. WellPoint, Inc. is an independent licensee of the Blue Cross Blue Shield Association and serves its members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as Blue Cross Blue Shield in 10 New York City metropolitan counties and as Blue Cross, Blue Shield or Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and through UniCare. Additional information about WellPoint is available at http://www.wellpoint.com .


'/>"/>
SOURCE WellPoint, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4Cambridge Scientists Archive 500,000th Crystal Structure 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3Health Robotics Announces First Five i v STATION 28TM 29 Robot Shipments and Receipt of 3L 3T Innovation Award 14435 1Health Robotics Announces First Five i v STATION 28TM 29 Robot Shipments and Receipt of 3L 3T Innovation Award 14435 2Health Robotics Announces First Five i v STATION 28TM 29 Robot Shipments and Receipt of 3L 3T Innovation Award 14435 3National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 1National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 2National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 3National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 4National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 5Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009 5383 1Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009 5383 2Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009 5383 3Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009 5383 4Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009 5383 5